🇺🇸 FDA
Pipeline program

saxagliptin

262-08-001

Phase 2 small_molecule completed

Quick answer

saxagliptin for Diabetes, Type 2 is a Phase 2 program (small_molecule) at KYOWA KIRIN AUSTRALIA PTY LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
KYOWA KIRIN AUSTRALIA PTY LTD
Indication
Diabetes, Type 2
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials